Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS) ( DrugBank: Human normal immunoglobulin )

3 diseases

ID	Disease name (Link within this page)	Number of trials
14	Chronic inflammatory demyelinating polyneuropathy	2
43	Microscopic polyangiitis	1
45	Eosinophilic granulomatosis with Polyangiitis	1

14. Chronic inflammatory demyelinating polyneuropathy

Clinical trials : 175 / Drugs : 161 - (DrugBank : 41) / Drug target genes : 13 - Drug target pathways : 24

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-142472	04/8/2014	13/03/2014	Phase 3 study of GGS in multifocal motor neuropathy (MMN)	Open-label, uncontrolled, before-and-after study of GGS in multifocal motor neuropathy (MMN) (Phase 3 study)	Multifocal motor neuropathy (MMN)	Intervention name : Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS) INN of the intervention : - Dosage And administration of the intervention : Intravenous drip infusion Control intervention name : - INN of the control intervention : - Dosage And administration of the control intervention : -	Teijin Pharma Limited	NULL	complete	20	74	BOTH	5	Phase 3	Japan
2	JPRN-JapicCTI-142471	10/3/2014	13/03/2014	Phase 3 study of GGS in chronic inflammatory demyelinating polyneuropathy (CIDP)	Open-label, uncontrolled, before-and-after study of GGS in chronic inflammatory demyelinating polyneuropathy (CIDP) (Phase 3 study)	Chronic inflammatory demyelinating polyneuropathy(CIDP)	Intervention name : Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS) INN of the intervention : - Dosage And administration of the intervention : Intravenous drip infusion Control intervention name : - INN of the control intervention : - Dosage And administration of the control intervention : -	Teijin Pharma Limited	NULL	complete	20	74	BOTH	30	Phase 3	Japan

Clinical trials : 88 / Drugs : 81 - (DrugBank : 21) / Drug target genes : 15 - Drug target pathways : 90

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-132394	07/3/2014	25/12/2013	Phase 3 study of GGS in patients with microscopic polyangiitis (MPA)	Randomized, placebo-controlled, double-blind, parallel-group clinical study of GGS in patients with microscopic polyangiitis (MPA) (Phase 3 study)	Microscopic polyangiitis (MPA)	Intervention name : Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS) INN of the intervention : - Dosage And administration of the intervention : Intravenous drip infusion Control intervention name : Placebo (physiological saline) INN of the control intervention : - Dosage And administration of the control intervention : Intravenous drip infusion	TEIJIN PHARMA LIMITED	NULL	complete	20		BOTH	36	Phase 3	Japan

Clinical trials : 31 / Drugs : 44 - (DrugBank : 18) / Drug target genes : 18 - Drug target pathways : 101

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-060242	01/2/2006		Phase 3 study of GGS in patients with CSS/AGA	Double-blind, Randomized clinical study of GGS (Intravenous Immunoglobulin) in patients with CSS/AGA. Phase 3 study.	Churg-Strauss Syndrome (CSS) / Allergic Granulomatous Angiitis (AGA)	Intervention name : Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS) Dosage And administration of the intervention : Intravenous drip infusion Control intervention name : Placebo (physiological saline) Dosage And administration of the control intervention : Intravenous drip infusion	TEIJIN PHARMA LIMITED	NULL		20	74	BOTH	21	Phase 3	NULL